Healthcare
Live Price
Offline$0.171
+0.00% today
1Y Change
+174.41%
Window
Jun 23, 2025 → Jun 19, 2026
Coverage: 257 bars · Jun 23, 2025 → Jun 19, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Pacific Edge Limited (PFGTF) is a Healthcare stock with a market cap of $140.00M and listed on OTC. The stock last traded around $0.17 and up 174.4% across the available one-year price window (Jun 23, 2025 → Jun 19, 2026). Baseline metrics include revenue growth of -16.2%, EPS growth of -1.6%, a dividend yield of 0.0%. What stands out right now is revenue -16.2%, EPS -1.6%, free cash flow +4.1% with operating margin -221.8% and ROIC -122.8%. Valuation already assumes a fairly strong business story at price/sales 8.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PFGTF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PFGTF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PFGTF Max Drawdown
-70.65%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PFGTF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.2M
-81.2% YoY
FY Net Income
-$14.2M
+28.1% YoY
Free Cash Flow
-$13.9M
+25.3% YoY
Revenue Growth
-16.2%
EPS Growth
-1.6%
Gross Margin
26.2%
Net Margin
-205.3%
Income statement
NZD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 22M | 26M | 20M | 11M | 2M |
| Gross Profit | 22M | 13M | 10M | 5M | -4M |
| Operating Income | -34M | -46M | -34M | -22M | -23M |
| EBITDA | -32M | -32M | -33M | -22M | -15M |
| Net Income | -30M | -30M | -27M | -20M | -14M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
NZD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 23M | 55M | 78M | 105M | 4M |
| Total Assets | 37M | 65M | 97M | 124M | 31M |
| Total Liabilities | 11M | 11M | 9M | 7M | 6M |
| Shareholder Equity | 26M | 55M | 88M | 117M | 25M |
| Total Debt | 3M | 4M | 1M | 2M | 3M |
| Net Debt | -20M | -25M | -77M | -103M | -1M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
14M
+22.7% YoY
Capital Expenditures
378K
+66.4% YoY
Free Cash Flow
14M
+25.3% YoY
Key ratios
Gross Margin
26.2%
Operating Margin
-221.8%
Net Margin
-205.3%
ROE
-130.4%
Debt / Equity
0.09x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.